WhiteLab Genomics

Paris, France Founded: 2019 • Age: 7 yrs
AI platform for drug discovery and development is provided.

About WhiteLab Genomics

WhiteLab Genomics is a Healthcare company based in Paris (France) founded in 2019 by Julien Cottineau and David Del Bourgo. AI platform for drug discovery and development is provided. WhiteLab Genomics has raised $36.24 million across 4 funding rounds from investors including Debiopharm, EIT Health and Omnes Capital. Its chief executive, as recorded, is David Del Bourgo. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.

Company details

WhiteLab Genomics was founded in 2019 and is based in Paris, France. Operations focus on the biotechnology sector, where an AI-driven platform is utilized to predict and identify potential drug candidate molecules. This technology supports therapeutic development by analyzing molecular data for pharmaceutical applications. Services are directed toward enhancing efficiency in drug discovery processes for research entities.

  • Headquarters Paris, France
  • Founders Julien Cottineau, David Del Bourgo
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website whitelabgx.com
  • Social LinkedIn X
Key Metrics
  • Total Equity Funding
    $36.24M (USD)

    in 4 rounds

  • Latest Funding Round
    $26M (USD), Series B

    Oct 2026

  • Investors
    Debiopharm

    & 4 more

Funding Insights of WhiteLab Genomics

WhiteLab Genomics has successfully raised a total of $36.24M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $26 million completed in October 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $36.24M
  • Total Rounds 4
  • Last Round Series B — $26M
  • First Round $44,800

    (Jul 2019)

  • Investors Count 5

All 4 funding rounds of WhiteLab Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2026$26MSeries B––
Sep 2022$10.12MSeries A–Debiopharm, Omnes Capital
–
Jun 2022$125,000Seed–Y Combinator
–
Jul 2019$44,800Grant––
Valuation history

5 investors in total: 5 institutional.

Investors in WhiteLab Genomics

WhiteLab Genomics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Debiopharm, EIT Health and Omnes Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity firm focused on energy transition and sustainable investments across Europe.
omnescapital.com
Early-stage startups are accelerated via funding and educational programs.
ycombinator.comMountain View, United States
Healthcare startups are accelerated and incubated through specialized programs.
2015eithealth.euMunich, Germany
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs
1979debiopharm.comLausanne, Switzerland
blast.club
Premium access

Investor details for WhiteLab Genomics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of WhiteLab Genomics

15 people are tracked at WhiteLab Genomics (7 in leadership, 8 in team).

NameRoleGroup
Julien Cottineau
Co-Founder & CSOLeadership
David Del Bourgo
Co-Founder & CEOLeadership
Lucia Cinque
Co-founder & Chief Of StaffLeadership
Dina Zielinski
Head Of Computational BiologyLeadership
Dylan SERILLON
Head Of Protein & Vector EngineeringLeadership
Domitille Halie
Head Of Scientific Project ManagementLeadership
Maud Thouverez
Head Of People And CultureLeadership
Abiramy Sinnadurai
MarketingTeam
Lélia Polit
Computational BiologistTeam
Perla El Darazi
Scientific Project ManagerTeam
Morgane Colléaux-Royer
Product ManagerTeam
Xi Liu
Senior Computational BiologistTeam
Xie Ting
Senior BioinformaticianTeam
Yanis Habtoun
Informaticien De La Recherche ScientifiqueTeam
Camille Alliot
Biologiste StructuralisteTeam
Premium access

Complete people profiles for WhiteLab Genomics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of WhiteLab Genomics

3 dated milestones of WhiteLab Genomics across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded WhiteLab Genomics is founded.
  2. Funding First funding round of $45K.
  3. Funding Latest funding round, Series B, of $26.0M.

Web traffic of WhiteLab Genomics

The website of WhiteLab Genomics (whitelabgx.com) receives about 6.1K visits a month.

  • Monthly visits
    6.1K

    ▲ 31.9% vs previous month

Similar websites

Websites whose visitors overlap most with WhiteLab Genomics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
basepairtech.com
100%
13.3K#1,123,186View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Whitelab Genomics

Premium access

Complete news archive for WhiteLab Genomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about WhiteLab Genomics

WhiteLab Genomics was founded in 2019.

WhiteLab Genomics is headquartered in Paris, France.

David Del Bourgo is the CEO of WhiteLab Genomics, as recorded in our data. They have also founded this company.

WhiteLab Genomics is a funded company, having raised a total of $36.24M across 4 funding rounds to date. The company's 1st funding round was a Grant of $44.8K, raised on Jul 2019.

WhiteLab Genomics was founded in 2019 and is based in Paris, France. Operations focus on the biotechnology sector, where an AI-driven platform is utilized to predict and identify potential drug candidate molecules. This technology supports therapeutic development by analyzing molecular data for pharmaceutical applications. Services are directed toward enhancing efficiency in drug discovery processes for research entities.

WhiteLab Genomics has 5 investors. Key investors include Debiopharm, EIT Health, Omnes Capital, Y Combinator, and Blast Club.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available